13D Filing: Alafi Capital Co LLC and Intra-Cellular Therapies Inc. (ITCI)

Page 5 of 12

Page 5 of 12 – SEC Filing


SCHEDULE 13D
CUSIP No. 46116X 101 Page
5
of 13 Pages
Item 1. Security and Issuer.

This Schedule 13D relates to the common stock, par value $0.0001
per share (the Common Stock) of Intra-Cellular Therapies, Inc., a Delaware corporation (Intra-Cellular or the Issuer). Intra-Cellulars principal executive offices are located at 430 East 29th Street, New York, NY 10016.

Item 2. Identity and Background.

Alafi Capital Company, LLC

(a) This Schedule 13D is being filed on behalf of Alafi Capital Company, LLC, a California limited liability company (Alafi
Capital, and together with Christopher Alafi, Ph.D. and Moshe Alafi, the Reporting Persons).

(b) The business address
of Alafi Capital is 8 Admiral Drive, Suite 324, Emeryville, CA 94608.

(c) The principal business of Alafi Capital is to invest in
healthcare companies.

(d) During the past five years, Alafi Capital has not been convicted in any criminal proceeding (excluding traffic
violations or similar misdemeanors).

(e) During the past five years, Alafi Capital has not been a party to a civil proceeding of a
judicial or administrative body of competent jurisdiction where as a result of such proceeding it was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.

(f) Not applicable.

Christopher Alafi, Ph.D.

(a) This Schedule 13D is being filed on behalf of Christopher Alafi, Ph.D.

(b) The business address of Dr. Alafi is c/o Alafi Capital Company, LLC, 8 Admiral Drive, Suite 324, Emeryville, CA 94608.

(c) Dr. Alafi is a managing partner of Alafi Capital Company, LLC, whose principal business is to invest in healthcare companies. In
addition, Dr. Alafi is a member of the board of directors of Intra-Cellular.

(d) During the past five years, Dr. Alafi has not
been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) During the past five years,
Dr. Alafi has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding he was or is subject to a judgment, decree or final order enjoining future violations of,
or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) Dr. Alafi is a citizen of the United States.

Moshe Alafi

(a) This
Schedule 13D is being filed on behalf of Moshe Alafi.

(b) The business address of Moshe Alafi is c/o Alafi Capital Company, LLC, 8
Admiral Drive, Suite 324, Emeryville, CA 94608.

(c) Moshe Alafi is a managing partner of Alafi Capital Company, LLC, whose principal
business is to invest in healthcare companies.

Follow Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

Page 5 of 12